Search Results - "Bowen, Scott J."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Type 2 inhibitor leads of human tropomyosin receptor kinase (hTrkA) by Subramanian, Govindan, Bowen, Scott J., Zhu, Yaqi, Roush, Nicole, Zachary, Theresa, Javens, Christopher, Williams, Tracey, Janssen, Ann, Gonzales, Andrea

    Published in Bioorganic & medicinal chemistry letters (01-10-2019)
    “…[Display omitted] In silico virtual screening using the ligand-based ROCS approach and the commercially purchasable compound collection from the ZINC database…”
    Get full text
    Journal Article
  2. 2

    Lead identification and characterization of hTrkA type 2 inhibitors by Subramanian, Govindan, Zhu, Yaqi, Bowen, Scott J., Roush, Nicole, White, Julie A., Huczek, Dennis, Zachary, Theresa, Javens, Christopher, Williams, Tracey, Janssen, Ann, Gonzales, Andrea

    Published in Bioorganic & medicinal chemistry letters (15-11-2019)
    “…Virtual in silico structure-guided modeling, followed by in vitro biochemical screening of a subset of commercially purchasable compound collection resulted in…”
    Get full text
    Journal Article
  3. 3

    Pro region engineering of nerve growth factor by deep mutational scanning enables a yeast platform for conformational epitope mapping of anti-NGF monoclonal antibodies by Medina-Cucurella, Angélica V, Zhu, Yaqi, Bowen, Scott J, Bergeron, Lisa M, Whitehead, Timothy A

    Published in Biotechnology and bioengineering (12-04-2018)
    “…Nerve growth factor (NGF) plays a central role in multiple chronic pain conditions. As such, anti-NGF monoclonal antibodies (mAbs) that function by…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Pro region engineering of nerve growth factor by deep mutational scanning enables a yeast platform for conformational epitope mapping of anti‐NGF monoclonal antibodies by Medina‐Cucurella, Angélica V., Zhu, Yaqi, Bowen, Scott J., Bergeron, Lisa M., Whitehead, Timothy A.

    Published in Biotechnology and bioengineering (01-08-2018)
    “…Nerve growth factor (NGF) plays a central role in multiple chronic pain conditions. As such, anti‐NGF monoclonal antibodies (mAbs) that function by…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Synthetic inhibitor leads of human tropomyosin receptor kinase A (TrkA) by Subramanian, Govindan, Vairagoundar, Rajendran, Bowen, Scott J, Roush, Nicole, Zachary, Theresa, Javens, Christopher, Williams, Tracey, Janssen, Ann, Gonzales, Andrea

    Published in RSC medicinal chemistry (01-03-2020)
    “…In silico virtual screening followed by in vitro biochemical, biophysical, and cellular screening resulted in the identification of distinctly different h TrkA…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Structure based design of novel irreversible FAAH inhibitors by Wang, Jane L., Bowen, Scott J., Schweitzer, Barbara A., Madsen, Heather M., McDonald, Joseph, Pelc, Matthew J., Tenbrink, Ruth E., Beidler, David, Thorarensen, Atli

    Published in Bioorganic & medicinal chemistry letters (15-10-2009)
    “…The design and synthesis a series of novel FAAH irreversible azetidine urea inhibitors from PF-3845 are described. Our SAR studies allowed us to optimize this…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Diffuse Vascular Spasm Associated With 4-Bromo-2,5-Dimethoxyamphetamine Ingestion by Bowen, J. Scott, Davis, Gary B, Kearney, Thomas E, Bardin, Joshua

    “…A 39-year-old previously healthy man experienced diffuse, progressive, peripheral arterial spasm 36 hours after the ingestion of concentrated high-grade…”
    Get full text
    Journal Article